Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud

Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud Wed, 21 Sep 2005 The latest in a series of fraud settlements, GlaxoSmithKline has agreed to pay $150 million to settle fraud allegations over inflating price of Zorfran and Kytril (nausea drugs) when billing Medicare…

British Psychiatrists Debate: "Clinical trials of antidepressant medications are producing meaningless results"

British Psychiatrists Debate: “Clinical trials of antidepressant medications are producing meaningless results” Wed, 27 Aug 2003 “The fact that most people support the psychopharmacological orthodoxy is, in itself, no argument and it is important to examine the evidence before drawing conclusions.” The psychiatric establishment is on trial–its foundation and claimed…

Practice Guidelines: Can We Trustthe Evidence in Evidence-Based Medicine?

Practice Guidelines: Can We Trustthe Evidence in Evidence-Based Medicine? Sun, 25 Sep 2005 “Research and Clinical Practice Guidelines: Can We Trust the Evidence in Evidence-Based Medicine?” is an article by Dr. John Abramson* (Harvard) and Dr. Barbara Starfeld (Distinguished Professor, Johns Hopkins), published in the Journal of the American Board…

| | | |

OHRP Letter to ARDSNetwork re: Investigation of Acute Respiratory DistressSyndrome

OHRP Investigation of experimental treatment for Acute Respiratory Distress Syndrome. ARDSNet studies: ARMA, FACCT, and ALVEOLI Table of Contents to Fax from OHRP page 1 Oct. 7, 2002 OHRP letter to: Ronald S. Newvbower, Ph.D(Mass. General Hospital), Lee E. Limbird, Ph.D. (Vanderbilt University), and Robert Kay, MD) (Cleveland Clinic Foundation)…